A research team has successfully designed and developed a proprietary non-precious metal oxygen evolution reaction (OER) catalyst featuring a layered structure optimized for anion exchange membrane ...

New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating TSC-related epilepsy Filana Therapeutics to begin trading ...

Spermidine, a polyamine, has been linked to longer lifespans, improved health, and lessening memory loss with age, and it’s ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...

Autoimmune and autoinflammatory diseases arise from complex interactions between host genetic susceptibility and environmental factors, particularly the gut ...

When the first performance of Cesar Franck’s Symphony in D Minor was given in Paris in 1889, critics were almost unanimously indignant. Sniffed one of them: “Why play this symphony here? Who is this M ...

Modulate, a conversational voice intelligence company, today introduced the Ensemble Listening Model (ELM), a new approach to artificial intelligence. Modulate's new ELM, Velma 2.0, combines spoken ...

For stem cells to differentiate into the appropriate cell-type, transcription factors (TFs) must be tailored to highly specific expression patterns of lineage-specific genes. Abnormalities in the ...

Modulate introduces VoiceVault, an advanced conversational AI solution designed to proactively detect and prevent fraud across voice channels, offering real-time analysis and intervention capabilities ...

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study led by the Hospital del Mar Research Institute and published in Nature ...